NCT06626438View on ClinicalTrials.gov

Treatable Traits in Interstitial Lung Disease

NARecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

September 3, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

July 31, 2027

Conditions
Interstitial Lung Diseases (ILD)
Interventions
OTHER

Treatable traits model of care

Embedded multidisciplinary clinic with treatable traits model of care.

Trial Locations (2)

6009

NOT_YET_RECRUITING

Sir Charles Gairdner Hospital, Perth

6150

RECRUITING

Fiona Stanley Hospital, Perth

All Listed Sponsors
collaborator

Fiona Stanley Hospital

OTHER

collaborator

Sir Charles Gairdner Hospital

OTHER

lead

The University of Western Australia

OTHER

NCT06626438 - Treatable Traits in Interstitial Lung Disease | Biotech Hunter | Biotech Hunter